Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ubiquitin ligases in oncogenic transformation and cancer therapy
Daniela Senft, Jianfei Qi, Ze’ev A. Ronai
Nature reviews. Cancer (2017) Vol. 18, Iss. 2, pp. 69-88
Open Access | Times Cited: 404

Showing 26-50 of 404 citing articles:

Genetic interactions of G-quadruplexes in humans
Katherine G. Zyner, Darcie S Mulhearn, Santosh Adhikari, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 107
The Emerging Roles of RNA Modifications in Glioblastoma
Zhen Dong, Hongjuan Cui
Cancers (2020) Vol. 12, Iss. 3, pp. 736-736
Open Access | Times Cited: 107
Ubiquitomics: An Overview and Future
George Vere, Rachel Kealy, Benedikt M. Kessler, et al.
Biomolecules (2020) Vol. 10, Iss. 10, pp. 1453-1453
Open Access | Times Cited: 103
Integrating the DNA damage and protein stress responses during cancer development and treatment
Vassilis G. Gorgoulis, Dafni‐Eleftheria Pefani, Ioannis S. Pateras, et al.
The Journal of Pathology (2018) Vol. 246, Iss. 1, pp. 12-40
Open Access | Times Cited: 98
Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
Simin Qi, Gang Cheng, Xiangdong Cheng, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 98
The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis
Xingyun Wang, Shilin Xia, Hongchang Li, et al.
Cell Death and Differentiation (2019) Vol. 27, Iss. 6, pp. 1747-1764
Open Access | Times Cited: 96
The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis
Tongde Du, Hongchang Li, Yongsheng Fan, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 95
FGFR3 Destabilizes PD-L1 via NEDD4 to Control T-cell–Mediated Bladder Cancer Immune Surveillance
Weiqiang Jing, Ganyu Wang, Zhiwei Cui, et al.
Cancer Research (2021) Vol. 82, Iss. 1, pp. 114-129
Open Access | Times Cited: 95
Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism
Nathan J. Schauer, Xiaoxi Liu, Robert S. Magin, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 90
HECT-Type E3 Ubiquitin Ligases in Cancer
Francesca Bernassola, Giovanni Chillemi, Gerry Melino
Trends in Biochemical Sciences (2019) Vol. 44, Iss. 12, pp. 1057-1075
Closed Access | Times Cited: 84
E1 Enzymes as Therapeutic Targets in Cancer
Samir H. Barghout, Aaron D. Schimmer
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 1-56
Open Access | Times Cited: 82
Ubiquitin–proteasome system and the role of its inhibitors in cancer therapy
Fatemeh Aziz‐Aliabadi, Beheshteh Sohrabi, Ebrahim Mostafavi, et al.
Open Biology (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 82
RBR E3 ubiquitin ligases in tumorigenesis
Peter Wang, Xiaoming Dai, Wenxiao Jiang, et al.
Seminars in Cancer Biology (2020) Vol. 67, pp. 131-144
Closed Access | Times Cited: 81
Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications
Shazia Sofi, Umar Mehraj, Hina Qayoom, et al.
Medical Oncology (2022) Vol. 39, Iss. 6
Closed Access | Times Cited: 69
Targeting ubiquitin signaling for cancer immunotherapy
Xiaofei Zhou, Shao‐Cong Sun
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 62
OTUD1 Activates Caspase‐Independent and Caspase‐Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation
Qingyu Luo, Xiaowei Wu, Pengfei Zhao, et al.
Advanced Science (2021) Vol. 8, Iss. 8
Open Access | Times Cited: 61
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
Man Chun John, Saber Tadros, Alyssa Bouska, et al.
Haematologica (2021) Vol. 107, Iss. 3, pp. 690-701
Open Access | Times Cited: 59
Insights in Post-Translational Modifications: Ubiquitin and SUMO
Daniel Salas‐Lloret, Román González‐Prieto
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3281-3281
Open Access | Times Cited: 54
Salivary Exosomal miRNA-1307-5p Predicts Disease Aggressiveness and Poor Prognosis in Oral Squamous Cell Carcinoma Patients
Aditi Patel, Shanaya Patel, Parina Patel, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10639-10639
Open Access | Times Cited: 41
INKILN is a Novel Long Noncoding RNA Promoting Vascular Smooth Muscle Inflammation via Scaffolding MKL1 and USP10
Wei Zhang, Jinjing Zhao, Lin Deng, et al.
Circulation (2023) Vol. 148, Iss. 1, pp. 47-67
Open Access | Times Cited: 36
TRAF3/STAT6 axis regulates macrophage polarization and tumor progression
Jianhong Shi, Lina Liu, Dandan Song, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 8, pp. 2005-2016
Closed Access | Times Cited: 33
Protein degradation: expanding the toolbox to restrain cancer drug resistance
Hui Ming, Bowen Li, Jingwen Jiang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 31
Ubiquitin–proteasome system as a target for anticancer treatment—an update
Yeon‐Jung Kim, Yeonjoo Lee, H. Y. Shin, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 7, pp. 573-597
Closed Access | Times Cited: 30
Targeting the Ubiquitin–Proteasome System and Recent Advances in Cancer Therapy
Daniela Spano, Giuliana Catara
Cells (2023) Vol. 13, Iss. 1, pp. 29-29
Open Access | Times Cited: 29
p53/MDM2 signaling pathway in aging, senescence and tumorigenesis
Youyi Huang, Xiaofang Che, Peter Wang, et al.
Seminars in Cancer Biology (2024) Vol. 101, pp. 44-57
Closed Access | Times Cited: 15

Scroll to top